Interact with your peers.
See what's being published in neurology and the neurosciences.
Best practice recommendations the first in Canada.
The protagonist of the study is the protein TDP-43 which accumulates in brain cells in 97% of cases of amyotrophic lateral sclerosis and in approximately 45% of those with frontotemporal dementia.
An experimental medication that was recently shown to slow the progression of amyotrophic lateral sclerosis has now demonstrated the potential to also prolong patient survival.
Print or email information for your patients when needed.
Explore other relevant websites. Close the window to return to MedLink.